| Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections J Mattner, KL DeBord, N Ismail, RD Goff, C Cantu III, D Zhou, ... Nature 434 (7032), 525-529, 2005 | 1364 | 2005 |
| Lysosomal glycosphingolipid recognition by NKT cells D Zhou, J Mattner, C Cantu III, N Schrantz, N Yin, Y Gao, Y Sagiv, ... Science 306 (5702), 1786-1789, 2004 | 1221 | 2004 |
| Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor DM Zajonc, C Cantu III, J Mattner, D Zhou, PB Savage, A Bendelac, ... Nature immunology 6 (8), 810-818, 2005 | 401 | 2005 |
| Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells RD Goff, Y Gao, J Mattner, D Zhou, N Yin, C Cantu, L Teyton, A Bendelac, ... Journal of the American Chemical Society 126 (42), 13602-13603, 2004 | 279 | 2004 |
| Liver autoimmunity triggered by microbial activation of natural killer T cells J Mattner, PB Savage, P Leung, SS Oertelt, V Wang, O Trivedi, ... Cell host & microbe 3 (5), 304-315, 2008 | 267 | 2008 |
| The role of type I interferons in non‐viral infections C Bogdan, J Mattner, U Schleicher Immunological reviews 202 (1), 33-48, 2004 | 257 | 2004 |
| A modified α-galactosyl ceramide for staining and stimulating natural killer T cells Y Liu, RD Goff, D Zhou, J Mattner, BA Sullivan, A Khurana, C Cantu III, ... Journal of immunological methods 312 (1-2), 34-39, 2006 | 243 | 2006 |
| Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities P Rausch, M Basic, A Batra, SC Bischoff, M Blaut, T Clavel, J Gläsner, ... International Journal of Medical Microbiology 306 (5), 343-355, 2016 | 184 | 2016 |
| Cytokines, Signaling Pathways, and Effector Molecules Required for the Control of Leishmania (Viannia) braziliensis in Mice FJS Rocha, U Schleicher, J Mattner, G Alber, C Bogdan Infection and immunity 75 (8), 3823-3832, 2007 | 115 | 2007 |
| Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope CE Martin, F Broecker, MA Oberli, J Komor, J Mattner, C Anish, ... Journal of the American Chemical Society 135 (26), 9713-9722, 2013 | 109 | 2013 |
| Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein Y Sagiv, K Hudspeth, J Mattner, N Schrantz, RK Stern, D Zhou, ... The Journal of Immunology 177 (1), 26-30, 2006 | 107 | 2006 |
| Bile acids and microbiota: multifaceted and versatile regulators of the liver–gut axis N Grüner, J Mattner International journal of molecular sciences 22 (3), 1397, 2021 | 103 | 2021 |
| Protection against progressive leishmaniasis by IFN-β J Mattner, A Wandersee-Steinhäuser, A Pahl, M Röllinghoff, ... The Journal of Immunology 172 (12), 7574-7582, 2004 | 91 | 2004 |
| Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major J Mattner, H Schindler, A Diefenbach, M Röllinghoff, I Gresser, C Bogdan European journal of immunology 30 (8), 2257-2267, 2000 | 83 | 2000 |
| Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids X Long, S Deng, J Mattner, Z Zang, D Zhou, N McNary, RD Goff, L Teyton, ... Nature chemical biology 3 (9), 559-564, 2007 | 75 | 2007 |
| C5a regulates NKT and NK cell functions in sepsis ME Fusakio, JP Mohammed, Y Laumonnier, K Hoebe, J Köhl, J Mattner The Journal of Immunology 187 (11), 5805-5812, 2011 | 73 | 2011 |
| The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain U Ritter, J Mattner, JS Rocha, C Bogdan, H Körner Microbes and Infection 6 (6), 559-565, 2004 | 73 | 2004 |
| Impact of microbes on the pathogenesis of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) J Mattner International Journal of Molecular Sciences 17 (11), 1864, 2016 | 64 | 2016 |
| Arginase impedes the resolution of colitis by altering the microbiome and metabolome J Baier, M Gänsbauer, C Giessler, H Arnold, M Muske, U Schleicher, ... The Journal of clinical investigation 130 (11), 2020 | 61 | 2020 |
| Invariant natural killer T‐cell neutralization is a possible novel therapy for human eosinophilic esophagitis M Rayapudi, P Rajavelu, X Zhu, A Kaul, R Niranjan, S Dynda, A Mishra, ... Clinical & translational immunology 3 (1), e9, 2014 | 61 | 2014 |
